C5F2-HCB is a CYP -mediated inhibitor of the biosynthesis of arachidonic acid epoxygenase product (±) 14,15-EET ( HY-150084 ), with an IC 50 of 3.1 μM. C5F2-HCB inhibits EET-driven oxidative phosphorylation ( OXPHOS ) associated with tumor hypoxia, converting an immunologically "cold" tumor microenvironment into a "hot" one. C5F2-HCB reverses the immune-excluded tumor microenvironment in ER + HER2 − breast cancer allograft models. C5F2-HCB can be used in research related to ER + HER2 − breast cancer .
Products | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.